The  ||| S:0 E:4 ||| DT
gasotransmitter  ||| S:4 E:20 ||| FW
hydrogen  ||| S:20 E:29 ||| FW
sulfide  ||| S:29 E:37 ||| FW
in  ||| S:37 E:40 ||| FW
hemodialysis  ||| S:40 E:53 ||| FW
patients  ||| S:53 E:62 ||| FW
Hydrogen  ||| S:62 E:71 ||| FW
sulfide ||| S:71 E:78 ||| FW
,  ||| S:78 E:80 ||| ,
H2S ||| S:80 E:83 ||| NNP
,  ||| S:83 E:85 ||| ,
is  ||| S:85 E:88 ||| VBZ
the  ||| S:88 E:92 ||| DT
third  ||| S:92 E:98 ||| JJ
endogenous  ||| S:98 E:109 ||| JJ
gas  ||| S:109 E:113 ||| NN
with  ||| S:113 E:118 ||| IN
cardiovascular  ||| S:118 E:133 ||| JJ
properties  ||| S:133 E:144 ||| NNS
( ||| S:144 E:145 ||| -LRB-
the  ||| S:145 E:149 ||| DT
others  ||| S:149 E:156 ||| NNS
are  ||| S:156 E:160 ||| VBP
nitric  ||| S:160 E:167 ||| JJ
oxide  ||| S:167 E:173 ||| NN
and  ||| S:173 E:177 ||| CC
carbon  ||| S:177 E:184 ||| NN
monoxide ||| S:184 E:192 ||| NN
) ||| S:192 E:193 ||| -RRB-
.  ||| S:193 E:195 ||| .
In  ||| S:195 E:198 ||| IN
fact ||| S:198 E:202 ||| NN
,  ||| S:202 E:204 ||| ,
among  ||| S:204 E:210 ||| IN
other  ||| S:210 E:216 ||| JJ
important  ||| S:216 E:226 ||| JJ
signaling  ||| S:226 E:236 ||| JJ
functions ||| S:236 E:245 ||| NNS
,  ||| S:245 E:247 ||| ,
H2S  ||| S:247 E:251 ||| NNP
plays  ||| S:251 E:257 ||| VBZ
a  ||| S:257 E:259 ||| DT
key  ||| S:259 E:263 ||| JJ
role  ||| S:263 E:268 ||| NN
in  ||| S:268 E:271 ||| IN
regulating  ||| S:271 E:282 ||| VBG
blood  ||| S:282 E:288 ||| NN
pressure ||| S:288 E:296 ||| NN
.  ||| S:296 E:298 ||| .
Cystathionine  ||| S:298 E:312 ||| NNP
ß-synthase ||| S:312 E:322 ||| NNP
,  ||| S:322 E:324 ||| ,
cystathionine  ||| S:324 E:338 ||| JJ
γ-lyase  ||| S:338 E:346 ||| NN
( ||| S:346 E:347 ||| -LRB-
CSE ||| S:347 E:350 ||| NNP
)  ||| S:350 E:352 ||| -RRB-
and  ||| S:352 E:356 ||| CC
3-mercaptopyruvate  ||| S:356 E:375 ||| CD
sulfurtransferase  ||| S:375 E:393 ||| NNS
are  ||| S:393 E:397 ||| VBP
the  ||| S:397 E:401 ||| DT
principal  ||| S:401 E:411 ||| JJ
enzymes  ||| S:411 E:419 ||| NNS
devoted  ||| S:419 E:427 ||| VBN
to  ||| S:427 E:430 ||| TO
H2S  ||| S:430 E:434 ||| CD
formation ||| S:434 E:443 ||| NN
.  ||| S:443 E:445 ||| .
We  ||| S:445 E:448 ||| PRP
have  ||| S:448 E:453 ||| VBP
recently  ||| S:453 E:462 ||| RB
shown  ||| S:462 E:468 ||| VBN
that  ||| S:468 E:473 ||| IN
H2S  ||| S:473 E:477 ||| CD
levels  ||| S:477 E:484 ||| NNS
are  ||| S:484 E:488 ||| VBP
decreased  ||| S:488 E:498 ||| VBN
in  ||| S:498 E:501 ||| IN
patients  ||| S:501 E:510 ||| NNS
on  ||| S:510 E:513 ||| IN
chronic  ||| S:513 E:521 ||| JJ
hemodialysis  ||| S:521 E:534 ||| NN
through  ||| S:534 E:542 ||| IN
the  ||| S:542 E:546 ||| DT
transcriptional  ||| S:546 E:562 ||| JJ
deregulation  ||| S:562 E:575 ||| NN
of  ||| S:575 E:578 ||| IN
the  ||| S:578 E:582 ||| DT
CSE  ||| S:582 E:586 ||| NNP
gene ||| S:586 E:590 ||| NN
,  ||| S:590 E:592 ||| ,
hinting  ||| S:592 E:600 ||| VBG
at  ||| S:600 E:603 ||| IN
the  ||| S:603 E:607 ||| DT
possibility  ||| S:607 E:619 ||| NN
that  ||| S:619 E:624 ||| IN
a  ||| S:624 E:626 ||| DT
link  ||| S:626 E:631 ||| NN
exists  ||| S:631 E:638 ||| VBZ
between  ||| S:638 E:646 ||| IN
this  ||| S:646 E:651 ||| DT
finding  ||| S:651 E:659 ||| NN
and  ||| S:659 E:663 ||| CC
hypertension  ||| S:663 E:676 ||| NN
and  ||| S:676 E:680 ||| CC
the  ||| S:680 E:684 ||| DT
high  ||| S:684 E:689 ||| JJ
cardiovascular  ||| S:689 E:704 ||| JJ
mortality  ||| S:704 E:714 ||| NN
typical  ||| S:714 E:722 ||| JJ
of  ||| S:722 E:725 ||| IN
these  ||| S:725 E:731 ||| DT
patients ||| S:731 E:739 ||| NNS
.  ||| S:739 E:741 ||| .
